Aerial view of a hemp farm at harvest in late afternoon, tall green hemp on one side and cut stalks drying in pale gold rows on the other, with a tractor and red mower working the line between them

Full Spectrum CBD After December 11: What a New SEC Filing Shows

Table of Contents

    If you buy full spectrum CBD, Friday, December 11 is the date to watch. That's when the new federal per-container cap on THC and similar cannabinoids takes effect, and a publicly traded CBD maker just told federal regulators what it expects that cap to do to its own shelf.

    In a quarterly report filed with the SEC on November 12, Charlotte's Web said that if the rules take effect as scheduled, "certain of the Company's full-spectrum products would no longer meet the federal definition of hemp." Same filing, next breath: its broad spectrum and isolate products "are not currently expected to be similarly affected."

    That's a plain, on-the-record answer from a company that makes these products. Here's what it means for the bottle in your cabinet.

    What the SEC filing says

    The Charlotte's Web Form 10-Q covers the quarter that ended September 30. It was signed November 12 by the company's chief executive and chief financial officer.

    The company wrote that it "is evaluating potential product reformulations and other actions" to soften the impact. It also noted that several bills in Congress could change the federal framework, with no guarantee any of them pass.

    So the company's own read is this: full spectrum is at risk, broad spectrum and isolate likely aren't, and reformulation is on the table.

    Why the new cap reaches full spectrum CBD

    Congress rewrote the federal definition of hemp in November 2025, in P.L. 119-37. According to the Congressional Research Service, finished hemp products will be capped at 0.4 milligrams of total THC and other cannabinoids with similar effects, combined, per container. In September 2026, a funding law, P.L. 119-103, extended most of that change to December 11.

    The cap doesn't mention CBD. It doesn't have to. Full spectrum products keep more of the plant, and the plant carries trace THC. Across a whole bottle, every one of those traces counts toward the same per-container cap. Jason Klimek, a member at Harris Beach Murtha Cullina and co-leader of the firm's cannabis industry team, put it plainly to Forbes on November 12: "Full-spectrum CBD was never meant to be psychoactive, but under the new definition trace THC is still THC."

    We walked through the per-container math, and how to read a lab report against it, in our earlier post, Will Your CBD Still Be Legal After December 11?

    What isn't caught, and what nobody knows yet

    This isn't a CBD ban. The cap counts THC and cannabinoids with similar effects, not CBD by name. That's why Charlotte's Web expects its isolate and broad spectrum lines to come through, while its full spectrum products are the ones at risk.

    Two big unknowns remain. Congress ordered the FDA to publish lists of which cannabinoids count, plus "additional information and specificity" about the word "container," within 90 days. That deadline was February 10. The CRS reported on October 28 that the FDA had published none of it, and Cannabis Business Times reported on November 12 that it still hadn't.

    On paper, the law describes a container only as the innermost packaging touching the product. How that works for a multi-pack or a box of single servings is the kind of detail the FDA was supposed to settle. Until it does, businesses are planning around a word the agency was told to define and hasn't. More in our post on the overdue FDA lists.

    The Medicare program caught in the middle

    That filing also touches a federal program. Under the CMS Substance Access Beneficiary Engagement Incentive, participating organizations in certain Medicare models may furnish eligible hemp products, up to $500 a year per eligible beneficiary. Medicare doesn't pay for the products. Even now the channel is narrow: CMS limits it to federally legal hemp products with no more than 0.3% delta-9 THC and excludes anything inhalable. The option opened for two models on April 1, 2026, and a third model can start offering it January 1, 2027.

    Charlotte's Web, which plans to supply the program, wrote: "Adoption of the program to date has been limited." It added that CMS's current eligibility rules accommodate certain of its full spectrum products, but that CMS has indicated those rules will be adjusted to align with federal law.

    CMS says as much on its own page: "If the legal limits on hemp-derived products changes, as with Section 781 of the FY2026 Agriculture Appropriations Act, CMS will adjust its definition in accordance with the law." One arm of the federal government built a tested, tightly controlled channel for hemp products. Another is about to shrink what can go through it. We covered the program's background in October.

    What a real framework would protect

    We've said it before and we'll keep saying it. Synthetic, lab-made intoxicants deserve to go. On November 12, products with cannabinoids the plant can't naturally produce lost federal hemp status, and we don't miss them.

    A trace-THC full spectrum tincture is a different product. Treating it the same as a lab-made high is the wrong call. What we're asking Congress for instead:

    • A minimum age of 21
    • Third-party lab testing on every finished product
    • Honest labels that show what's in the container
    • An FDA that publishes the definitions it owes, before enforcement starts

    Nothing changes on your shelf until December 11. Between now and then, ask the shop or brand you buy from two things: whether they plan to reformulate, and whether you can see the lab report for the product you use. If a product you count on is going away, or your business is rebuilding a product line to fit the cap, that's the story lawmakers need to hear.

    Congress set December 11, and it already moved the date once. It can act again. Lawmakers need to hear from the people who buy, make and sell full spectrum products before the cap lands. Regulate it. Don't eliminate it.

    Tell Congress to regulate hemp, not erase it: take action here.

    Sources

    Share information about your brand with your customers. Describe a product, make announcements, or welcome customers to your store.